NEW YORK, Aug. 24, 2023 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Syneos Health, Inc. (“Syneos” or the “Company”) (NASDAQ: SYNH) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Syneos investors who were adversely…
Month: August 2023
NEW YORK, Aug. 24, 2023 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Aldeyra Therapeutics, Inc. (“Aldeyra” or the “Company”) (NASDAQ: ALDX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Aldeyra investors who were…
NEW YORK, Aug. 24, 2023 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Apellis Pharmaceuticals, Inc. (“Apellis” or the “Company”) (NASDAQ: APLS) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Apellis investors who were…
NEW YORK, Aug. 24, 2023 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Verizon Communications Inc. (“Verizon” or the “Company”) (NYSE: VZ) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Verizon investors who were…
NEW YORK, Aug. 24, 2023 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Shift4 Payments, Inc. (“Shift4” or the “Company”) (NYSE: FOUR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Shift4 investors who were adversely…
NEW YORK, Aug. 24, 2023 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Live Nation Entertainment, Inc. (“Live Nation” or the “Company”) (NYSE: LYV) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Live Nation investors…
NEW YORK, Aug. 24, 2023 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Proterra Inc. (“Proterra” or the “Company”) (NASDAQ: PTRA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Proterra investors who were adversely…
NEW YORK, Aug. 24, 2023 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in BioXcel Therapeutics, Inc. (“BioXcel” or the “Company”) (NASDAQ: BTAI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of BioXcel investors who were…
GÖTEBORG, Sweden, Aug. 24, 2023 /PRNewswire/ — Continued divestments in a strong vessel market Total income Q2: SEK 114.7 (180.8) million HY1: SEK 210.3 (304.9) million EBITDA Q2: SEK 72.1 (102.7) million HY1: SEK 109.8 (132.4) million Result before tax Q2: SEK 43.3 (36.5) million HY1:…
GÖTEBORG, Sweden, Aug. 24, 2023 /PRNewswire/ — Continued divestments in a strong vessel market Total income Q2: SEK 114.7 (180.8) million HY1: SEK 210.3 (304.9) million EBITDA Q2: SEK 72.1 (102.7) million HY1: SEK 109.8 (132.4) million Result before tax Q2: SEK 43.3 (36.5) million HY1:…